These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8930031)

  • 41. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera.
    Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y
    J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity.
    Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of association between autism and anti-GM1 ganglioside antibody.
    Moeller S; Lau NM; Green PH; Hellberg D; Higgins JJ; Rajadhyaksha AM; Alaedini A
    Neurology; 2013 Oct; 81(18):1640-1. PubMed ID: 24068789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease.
    Voumvourakis C; Rombos A; Konstantoulakis MM; Segditsa I; Papageorgiou C
    Acta Neurol Scand; 1992 Dec; 86(6):599-602. PubMed ID: 1481647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease.
    Koutsouraki E; Hatzifilippou E; Michmizos D; Banaki T; Costa V; Baloyannis S
    J Alzheimers Dis; 2014; 42 Suppl 3():S163-6. PubMed ID: 24898654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variation of myelin basic protein and its antibody in serum in senile dementia patients.
    Ge W; Cheng Y; Zhang S; Ye S; Chen J; Wang R; Li C
    Chin Med Sci J; 2000 Mar; 15(1):28. PubMed ID: 12899395
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies against gangliosides GM1 of patients with multiple sclerosis alter the response of neurons to synaptic activation.
    Sergeeva SS; Zaprianova E; Sotnikov OS; Deleva D; Filchev A; Sultanov B
    Dokl Biol Sci; 2004; 399():461-3. PubMed ID: 15717608
    [No Abstract]   [Full Text] [Related]  

  • 50. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
    J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
    Näsman B; Olsson T; Bäckström T; Eriksson S; Grankvist K; Viitanen M; Bucht G
    Biol Psychiatry; 1991 Oct; 30(7):684-90. PubMed ID: 1835658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.
    Fillit HM; Kemeny E; Luine V; Weksler ME; Zabriskie JB
    J Gerontol; 1987 Mar; 42(2):180-4. PubMed ID: 2950160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.
    Mecocci P; Parnetti L; Romano G; Scarelli A; Chionne F; Cecchetti R; Polidori MC; Palumbo B; Cherubini A; Senin U
    J Neuroimmunol; 1995 Mar; 57(1-2):165-70. PubMed ID: 7706432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias?
    Kowal L; Gajus MA; Kornberg AJ
    Clin Exp Ophthalmol; 2004 Aug; 32(4):411-4. PubMed ID: 15281977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testing for serum IgM binding to GM1 ganglioside in clinical practice.
    Pestronk A
    Neurology; 2000 Jun; 54(12):2353-4. PubMed ID: 10881275
    [No Abstract]   [Full Text] [Related]  

  • 57. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Ala TA; Frey WH
    Ann Neurol; 1994 Sep; 36(3):455. PubMed ID: 8080261
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy.
    Carpo M; Allaria S; Scarlato G; Nobile-Orazio E
    Neurology; 1999 Dec; 53(9):2206-7. PubMed ID: 10599811
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer's dementia.
    Serot JM; Bene MC; Faure GC
    Hum Pathol; 1994 Nov; 25(11):1185-90. PubMed ID: 7959663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.